TEAMM Updates

The TEAMM trial results were presented at The American Society of Haematology Conference in December 2017.

Tackling Early Morbidity and Mortality in Myeloma (TEAMM): Assessing the Benefit of Antibiotic Prophylaxis and Its Effect on Healthcare Associated Infections in 977 Patients: http://www.bloodjournal.org/content/130/Suppl_1/903

Diagnostic Pathways of Myeloma Patients Presenting to Hospital Care and Relationship to End Organ Damage: An Analysis from the Teamm (Tackling EArly Morbidity and Mortality in Myeloma) Trial in 977 Patients: http://www.bloodjournal.org/content/130/Suppl_1/2132

Assessment of Anti-Bacterial Antibodies in Multiple Myeloma Patients at Disease Presentation and in Response to Therapy, Implication for Patient Management: http://www.bloodjournal.org/content/130/Suppl_1/3036

Myeloma UK: https://www.myeloma.org.uk/news/trial-shows-positive-results-for-reducing-infections-in-myeloma-patients/

CRUK: https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-antibiotic-prevent-infections-people-having-treatment-myeloma-teamm

Thank you to all of the patients and hospitals that took part in the trial.